KOMBINATIONSBEHANDLUNG VON KREBS

European patent · EP2785349 · In force

Register entry

Publication number
EP2785349
Application number
EP12795842
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Maintained in amended form
Filed
Nov 30, 2012
Published
Oct 8, 2014
Granted
Oct 16, 2019
Protection ends at the latest
Nov 29, 2032
Next annual fee due
Nov 30, 2026
IPC classes
A61K 31/519 (2006.01)
A61P 35/00 (2006.01)
A61K 31/277 (2006.01)
A61K 31/4166 (2006.01)
A61K 31/58 (2006.01)
A61K 31/5025 (2006.01)
A61P 13/08 (2006.01)
Priority
US 201161564975 P 30.11.2011
PCT application
PCT/GB2012/052969 30.11.2012
PCT publication
WO2013/079964 06.06.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Oct 12, 2022

    Change

    Published in Swissreg on 12.10.2022

  6. Feb 9, 2022

    Change

    Published in Swissreg on 09.02.2022

  7. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  8. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

1 earlier entry
  1. Oct 16, 2019

    Granted

    Published in Swissreg on 16.10.2019

Parties

Holder

AstraZeneca AB

Astrazeneca AB

151 85 Södertälje, SE

Inventor

DAVIES, Barry, Robert

Macclesfield Cheshire SK10 4TG, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.